Table 2. Cyto-histopathological evaluation of cystic lesions (N = 48).
| Category | No of cases | NO of BX | Histopathology diagnosis | RON | ROM |
|---|---|---|---|---|---|
| I | 11 (22.9%) | 8 | Mucus retention cyst(1), Cystic lymphangioma(1), WT(2), PA(2), LGMEC(2) | 87.50% | 25% |
| II | 12 (25%) | 4 | Epidermal inclusion cyst, Mucus retention cyst, Lymphoepithelial cyst, LGMEC | 25% | 25% |
| III | 3 (6.25%) | 3 | LGMEC(3) | 100% | 100% |
| IVA | 8 (16.66%) | 7 | PA(1), Schwannoma(2), WT(4) | 100% | 00% |
| IVB | 6 (12.5%) | 2 | Cellular PA, Epithelial myoepithelial carcinoma | 100% | 50% |
| V | 2 (4.16%) | 2 | LGMEC | 100% | 100% |
| VI | 6 (12.5%) | 6 | WT(1), LGMEC(4), SCa(1) | 100% | 83.33% |
| Total | 48 (100%) | 32(66.6%) | 87.5% | 43.75% |
ROM was highest in category III and V (100%) followed by category VI (83.3%)